Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Amit D. Raval"'
Autor:
Amit D. Raval, Michael L. Ganz, Kathy Fraeman, Andrea L. Lorden, Shanmugapriya Saravanan, Yuexin Tang, Carlos A. Q. Santos
Publikováno v:
Transplant International, Vol 37 (2024)
Graphical Abstract
Externí odkaz:
https://doaj.org/article/14701fa0d6e94a8dadbc385e0ba21aa2
Autor:
Amit D. Raval, Michael L. Ganz, Kathy Fraeman, Andrea L. Lorden, Shanmugapriya Saravanan, Yuexin Tang, Carlos A. Q. Santos
Publikováno v:
Transplant International, Vol 35 (2022)
Limited data exist on cytomegalovirus (CMV) antiviral treatment patterns among kidney transplant recipients (KTRs). Using United States Renal Database System registry data and Medicare claims (1 January 2011–31 December 2017), we examined CMV antiv
Externí odkaz:
https://doaj.org/article/b1eb29c4abc5421c8310d594946176ce
Autor:
Amit D. Raval, Malcolm D. Mattes, Suresh Madhavan, Xiaoyun Pan, Wenhui Wei, Usha Sambamoorthi
Publikováno v:
Journal of Diabetes Research, Vol 2016 (2016)
Objective. To examine the association between metformin use and cancer stage at diagnosis among elderly men with preexisting diabetes mellitus and incident prostate cancer. Methods. This study used a population-based observational cohort of elderly m
Externí odkaz:
https://doaj.org/article/3659c13d50d843019b841f6d055f1a4b
Autor:
Amit D. Raval, Usha Sambamoorthi
Publikováno v:
Journal of Thyroid Research, Vol 2012 (2012)
Objective. To estimate incremental healthcare expenditures associated with thyroid disorders among individuals with diabetes. Research Design and Methods. Cross-sectional study design with data on adults over 20 years of age with diabetes (N=4,490) f
Externí odkaz:
https://doaj.org/article/d433cf2c03014263ab62300da11b5456
Publikováno v:
Revista Médica Clínica Las Condes, Vol 24, Iss 5, Pp 878-879 (2013)
Antecedentes: Las estatinas, como agentes hipolipemiantes con acciones pleiotrópicas, probablemente no sólo mejoran la dislipidemia asociada con el síndrome de ovario poliquístico sino que también pueden ejercer otros efectos beneficiosos metab
Externí odkaz:
https://doaj.org/article/48c26fed08f1410195f3dfd864166b7e
Publikováno v:
Transplant Infectious Disease. 25
Leukopenia and neutropenia (L/N) may affect treatment decisions, potentially resulting in poor clinical and economic outcomes among kidney transplant recipients (KTRs). The burden of L/N is poorly quantified systematically. This systematic literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63fe3ef93e60f63558adf63c6780fc9
https://doi.org/10.1111/tid.14000
https://doi.org/10.1111/tid.14000
Publikováno v:
Open Forum Infectious Diseases. 10
Background A systematic review and meta-analysis of real-world observational studies was conducted to summarize the impact of letermovir cytomegalovirus (CMV) primary prophylaxis (PP) among adult allogeneic hematopoietic cell transplant (allo-HCT) re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d837769ea834498f3600225d51a2f8a
https://doi.org/10.1093/ofid/ofac687
https://doi.org/10.1093/ofid/ofac687
Publikováno v:
Open Forum Infectious Diseases. 9
Background Valganciclovir (VGCV) prophylaxis is commonly utilized to prevent cytomegalovirus (CMV) infection among high (D+/R-) and intermediate (R+) risk kidney transplant recipients (KTRs). Due to the myelosuppressive effects of VGCV, KTRs may be a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8034ada594931c492795bf25b254ea0a
https://doi.org/10.1093/ofid/ofac492.287
https://doi.org/10.1093/ofid/ofac492.287
Autor:
Jan Styczynski, Gloria Tridello, Nina Knelange, Lotus Wendel, Alienor Xhaard, Ilaria Cutini, Patrizia Chiusolo, Georg-Nikolaus Franke, Sabina Kraus, Amit D Raval, Sanjay Merchant, Rafael de la Camara
Publikováno v:
Open Forum Infectious Diseases. 9
Background Letermovir (LET) prophylaxis in CMV seropositive (R+) allogeneic (allo) HCT recipients was approved in 2017 based on a Phase 3 randomized clinical trial (RCT) demonstrating lower rates of CMV infection, disease, and all-cause mortality amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2f0ad6a77c491f07a790296856521cc
https://doi.org/10.1093/ofid/ofac492.1291
https://doi.org/10.1093/ofid/ofac492.1291
Publikováno v:
Open Forum Infectious Diseases. 9
Background Kidney transplant recipients (KTRs) are commonly prescribed valganciclovir/ganciclovir (V/G) prophylactically to prevent cytomegalovirus (CMV) infection; however, prolonged exposure to these medications is associated with an increased risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb917d5e0d1a027d0583aaf63d0b08bd
https://doi.org/10.1093/ofid/ofac492.284
https://doi.org/10.1093/ofid/ofac492.284